News / Business
Synta Pharmaceuticals Corp (NASDAQ:SNTA) to Hold Q4 2007 Earnings Conference Call March 25
Synta Pharmaceuticals Corp (NASDAQ:SNTA) will hold a conference call on Tuesday, March 15 at 8:30 pm to discuss the fourth quarter earnings for 2007.
A biopharmaceutical company, Synta Pharmaceuticals is focused on the discovery, development and commercialization of small molecule drugs to treat severe medical conditions with potential markets, such as cancer and chronic inflammatory diseases.
The company’s pipeline includes clinical and preclinical stage drug candidates featuring distinct mechanisms of action and chemical structures.
Synta holds all rights to its drug candidates and programs in all geographic markets and therapeutic indications.
STA-4783 is the company’s most advanced clinical stage drug candidate. It is an injectable small molecule compound to treat a variety of solid tumor cancers.
Three other drug candidates have been discovered and developed by the company. They are currently in clinical and pre clinical development.
Synta Pharmaceuticals Corp (NASDAQ:SNTA)
To view more Conference Call related events or to post your own events, visit:
